Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Edetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE known ✓ | P12821 | 1/20 | 0.50 |
| ▸ | CA4 known ✓ | P22748 | 8/20 | 0.42 |
| ▸ | CA2 known ✓ | P00918 | 4/20 | 0.36 |
| ▸ | CA1 known ✓ | P00915 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.76 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | EYA2 | O00167 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL42427 | 1.00 | KDM4E (0.76) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL3835316 | 1.00 | KDM4E (0.76) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL906 | 1.00 | KDM4E (0.76) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL978169 | 0.97 | KDM4E (0.73) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL865416 | 0.97 | KDM4E (0.73) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL10942494 | 0.97 | KDM4E (0.73) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Pentetic Acid SCHEMBL342065 | 0.97 | KDM4E (0.81) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL8675893 | 0.97 | KDM4E (0.73) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL16004809 | 0.97 | KDM4E (0.73) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL6669353 | 0.97 | KDM4E (0.73) | KDM4EALOX15MAPTSMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2062467-B1 | ARTICLE WITH A COATING OF ELECTRICALLY CONDUCTIVE POLYMER AND PRECIOUS/SEMIPRECIOUS METAL AND PROCESS FOR PRODUCTION THEREOF | ENTHONE (US) | 2012-02-15 | — | — | EP | claimed |
| EP-1553053-B2 | The use of calcium carbonate in an acidic aqueous medium | MINERALS TECH INC (US) | 2011-05-04 | — | — | EP | claimed |
| EP-2316861-A1 | Nitrile rubbers | LANXESS Deutschland GmbH (DE) | 2011-05-04 | — | — | EP | claimed |
| EP-2316860-A1 | Nitrile rubbers | LANXESS Deutschland GmbH (DE) | 2011-05-04 | — | — | EP | claimed |
| US-20240001485-A1 | A LASER ETCHING METHOD FOR MEMS PROBES | MAXONE SEMICONDUCTOR CO., LTD. (CN) | 2024-01-04 | — | — | US | disclosed |
| US-8153271-B2 | Article with a coating of electrically conductive polymer and precious/semiprecious metal and process for production thereof | ORMECON GMBH (DE) | 2012-04-10 | — | — | US | disclosed |
| US-8129338-B2 | Nitric oxide-blocked cross-linked tetrameric hemoglobin | IKOR, INC. (US) | 2012-03-06 | — | — | US | disclosed |
| US-20120039905-A1 | The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection | THE BABRAHAM INSTITUTE | 2012-02-16 | — | — | US | disclosed |
| EP-2062467-B1 | ARTICLE WITH A COATING OF ELECTRICALLY CONDUCTIVE POLYMER AND PRECIOUS/SEMIPRECIOUS METAL AND PROCESS FOR PRODUCTION THEREOF | ENTHONE (US) | 2012-02-15 | — | — | EP | disclosed |
| US-20120027742-A1 | METHODS FOR TREATING ADULT RESPIRATORY DISTRESS SYNDROME | COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2012-02-02 | — | — | US | disclosed |
| US-20110281292-A1 | Compositions and methods for identifying antigens which elicit an immune response | CHEN SI-YI (US) | 2011-11-17 | — | — | US | disclosed |
| US-20110257080-A1 | Hepatitis B Virus Compositions and Methods of Use | FOX CHASE CANCER CENTER | 2011-10-20 | — | — | US | disclosed |
| EP-2316423-A1 | Parenteral formulations of dopamine agonists | VeroScience LLC (US) | 2011-05-04 | — | — | EP | disclosed |
| EP-2316861-A1 | Nitrile rubbers | LANXESS Deutschland GmbH (DE) | 2011-05-04 | — | — | EP | disclosed |
| WO-2011038002-A1 | IMMUNOGENIC EPITOPES AS TARGETS FOR UNIVERSAL CANCER VACCINES | YALE UNIVERSITY (US) | 2011-03-31 | — | — | WO | disclosed |
| EP-2299812-A1 | TARGETING TGF- AS A THERAPY FOR ALZHEIMER'S DISEASE | Yale University (US) | 2011-03-30 | — | — | EP | disclosed |
| US-7868158-B2 | Modulation of cytokine signaling regulators and applications for immunotherapy | BAYLOR COLLEGE OF MEDICINE (US) | 2011-01-11 | — | — | US | disclosed |
| US-7868159-B2 | Modulation of negative immune regulators and applications for immunotherapy | BAYLOR COLLEGE OF MEDICINE (US) | 2011-01-11 | — | — | US | disclosed |
| WO-2007038524-A2 | COCRYSTALLIZATION METHODS | SSCI, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
| US-5919291-A | LIQUID EXTRACTED FROM AT LEAST ONE TYPE OF MALVACEAE, ORCHIDACEAE AND ALOE IS USED AS THE WATER-SOLUBLE FUNGUSPROOFING AGENT. | MINOLTA CO., LTD. (JP) | 1999-07-06 | — | — | US | disclosed |